Prof. Florian Lordick, ESMO GI 2026 Scientific Committee member, invites you to Munich — onsite or online — for a key GI oncology meeting of the year.

🗓️ 1–4 July 2026
⏰ Early reg: 15 April
👉 Register now: https://ow.ly/FtGR50YcGIt

#ESMOGI26 #esmomeetings

👉 Stay ahead of emerging #toxicity challenges in next‑gen #immunotherapies. Get insights from experts and join the live Q&A.

🔗 Register now and earn 1 ESMO-MORA point: https://ow.ly/HMns50YcO6k

#ESMOOnAir #ESMOWebinars

👉 Prof. David Thomas, Sydney, Australia, ESMO Sarcoma and Rare Cancers 2026 Scientific Co-Chair, invites you to join a gathering where rare cancers research comes together to drive real-world impact. Register now!
🔗 https://ow.ly/PCAR50Yclm5
#ESMORareCancers26 #esmomeetings

🎥 Hear Jarushka Naidoo on why #ELCC26 is an intimate meeting where young oncologists meet experts, ask questions & build mentorships.

⏳ Late registration ends 25 Feb. Secure your seat (onsite in Copenhagen & online): 🔗 https://ow.ly/GMof50YcHbj

#LungCancer #esmomeetings

#ICHNO26 🔔 Late registration is still open!
Register by 25 Feb
🔗 https://ow.ly/ALal50YbKWf
Strengthen clinical decision-making with cutting-edge science, randomised trial updates & multidisciplinary expert exchange

📍 Seville | 19–21 March 2026

#HeadAndNeckOncology #esmomeetings

📣#ESMOGynae26: From breakthroughs in ovarian cancer therapies to new hope for rare tumours, every session is designed to bring us closer to better outcomes, earlier diagnoses, and more personalised care
⏰Share your research by 31 March 2026
#esmomeetings
🔗 https://ow.ly/MhOS50Y9XcE

📣ESMO #ClinicalPracticeGuideline on #Lymphomas - New Living Guideline recommendations in the relapsed/refractory setting:
- Epcoritamab combinations and odronextamab in Follicular Lymphoma
- Sonrotoclax in Mantle Cell Lymphoma thrid-line or later

🔗 https://ow.ly/v7Uo50YcbSE

📣 #ESMO26: Secure your stay and join us in Madrid, Spain, from 23 to 27 October 2026.
#esmomeetings

🔗 https://ow.ly/LPq250Y9Trc

📣Updated ESMO #ClinicalPracticeGuideline on advanced and metastatic #ProstateCancer:
✅ Substantial advances in castration-sensitive & -resistant prostate cancer
✅ Updated algorithms & recommendations reflecting latest clinical data
#ESMOGuidelines Christopher Sweeney

🔗 https://ow.ly/E4ov50Yc8e2

📣 #ESMO26: Where the world of oncology meets and the future of cancer care takes shape. Abstract submission system now open!
⏰Deadline 12 May 2026

👉 Share your groundbreaking research
- Gain global recognition
- Present LIVE in Madrid
#esmomeetings

🔗 https://ow.ly/utHu50Y9bHC

👉 From data to impact.
Discover how your abstract can help shape progress in GI cancer care at ESMO GI 2026, Munich, 1–4 July 2026.
#ESMOGI26 #esmomeetings

SUBMIT YOUR ABSTRACT NOW!
🔗 https://ow.ly/HQLX50Y8NgY

⏰ Still time to save on #ELCC26 registration. Reduced fees available until 25 Feb
Join the thoracic oncology community in Copenhagen and online, 25–28 March. Secure your seat

🔗 https://ow.ly/TBOQ50Y8Oe6

New evidence, case‑based insights & multidisciplinary exchange
#esmomeetings

👉 Prof. Eva Tiensuu Janson, Uppsala, Sweden, ESMO Sarcoma and Rare Cancers 2026 Scientific Co-Chair, invites you to meet peers and experts shaping the future of rare cancer care. ⏰ Register by 11 Feb and save! #ESMORareCancers26 #esmomeetings

🔗 https://ow.ly/xX5150Y5hzj

On #WorldCancerDay, ESMO joins the global call to place people at the centre of #CancerCare, promoting patient-centred oncology adjusted to the individual characteristics of each person - a vision at the core of the ESMO Roadmap 2030. #UnitedByUnique"https://bsky.app/profile/did:plc:drpwylth67p6y4jl3xi7paou" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">ByUnique
📌 <a href="https://ow.ly/YBUW50Y8E3k" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">https://ow.ly/YBUW50Y8E3k

🌐 #ESMODeepDive webinar: #MIBC - from evidence to practice with ctDNA, perioperative optimisation & bladder‑sparing.

Live Q&A 💬 ESMO member: register to secure your seat: 🔗 https://ow.ly/zXQK50Y5hbt

#ESMOWebinar #ESMOOnAir #BladderCancer #Oncology #PrecisionMedicine

Lars Dyrskjøt Nick James

📣 #ESMOBreast26: An event to advance knowledge across the entire spectrum of breast oncology, where cutting-edge science, networking and innovation await.

⏰ Benefit from big savings if you register before 26 February 2026
🔗 https://ow.ly/vREN50Y5goF

#esmomeetings

⏰ Final call for #MCCRWorkshop — applications close 30 Jan.

✅ 1 week focused on your clinical trial protocol
✅ Expert mentorship & small‑group discussions
📅 13–18 June 2026 — Sint Michielsgestel, NL

🔗 Apply now: https://ow.ly/bYuG50Y5g9n

European Organisation for Research and Treatment of Cancer

Standing by those who care about cancer, we have advanced #education strengthened connections and helped shape sustainable #CancerCare systems over the past years. Your contribution made this possible.
@fandremd.bsky.social

📣ESMO #ClinicalPracticeGuideline Express Update on #EpithelialOvarianCancer:
- Rucaparib: 1st-line PARPi maintenance option
- MIRV: for recurrent FRα-high #OvarianCancer after 1-3 prior therapies & PFI <6 months

🔗 https://ow.ly/J06u50Y4HT8

#GYNOnc #Oncology #ESMOGuidelines

📣 #PatientAdvocate Workshops at #ESMORareCancers26
13–14 Mar
✅ #HTA & patient input
✅ Rare cancer research
✅ Care via reference centres, guidelines & outcomes
✔️ Registration required | ESMO Advocates: reduced fee, late 11 Feb
❌ No travel grants

🔗 https://ow.ly/afrN50Y494L

📣 ESMO #ClinicalPracticeGuideline Express Update on Localised #ColonCancer: 💡CHALLENGE trial suggests survival benefits from structured exercise
👥Selected resected patients to be informed & encouraged to participate #Oncology #ESMOGuidelines

🔗 https://ow.ly/lJY850Y49fR

👉 Join us for the #ESMOGuidelines webinar to get practical insights on ctDNA, NGS, MSI‑H/dMMR and targeted treatments to support personalised #CRC care.

Open to all ESMO account holders.

🔗Register here: https://ow.ly/kE7S50Y1Ljw
#ESMOWebinar #ESMOOnAir #CancerGuidelines

📣 #ESMOBreast26: Last 24 hours to share your studies! Contribute to a meeting recognised for its scientific depth and commitment to advancing breast cancer care. Don’t wait—submit now!
⏰ Deadline: 27 January 2026
#esmomeetings

🔗 buff.ly/hOEmpXL

Save the date for the next #YO4YO Clinical Case Discussion session with @guinadermarta.bsky.social , Ann Partridge and Matteo Lambertini.
📌 #Pregnancy-associated #cancer: Clinical challenges and ethical insights
#ESMOYOC
📅 9 February 2026
🕒 14:00-15:00 CET
🔗 https://ow.ly/9T7a50Y1xQw

📣 Register now! Join ESMO GI 2026, the global meeting point where collaboration thrives and science moves into practice in GI oncology. See you in Munich, Germany, 📅 from 1 to 4 July 2026. #ESMOGI26 #esmomeetings

🔗 buff.ly/yRXZQxI